Last reviewed · How we verify
Intraarticular betamethasone — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intraarticular betamethasone (Intraarticular betamethasone) — Hvidovre University Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intraarticular betamethasone TARGET | Intraarticular betamethasone | Hvidovre University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intraarticular betamethasone CI watch — RSS
- Intraarticular betamethasone CI watch — Atom
- Intraarticular betamethasone CI watch — JSON
- Intraarticular betamethasone alone — RSS
Cite this brief
Drug Landscape (2026). Intraarticular betamethasone — Competitive Intelligence Brief. https://druglandscape.com/ci/intraarticular-betamethasone. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab